Danish pharma industry expects minimal impact from healthcare reform
The Danish Medicines Council subsists in the government's reform of the health sector, and according to companies and the industry association the proposal will have limited impact on the pharmaceutical industry.
The Danish Medicines Council will remain the responsible body for assessing new medicines, and the government's reform of the Danish health sector will thus have little impact on the medicines industry's terms of sale in Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
